The second half of this article describes the testing methods used by the authors to demonstrate the applicability of single-use mixing technology for virus inactivation.
Eve DePauw
Advertisement
Eve DePauw is downstream process technician at the Bioengineering unit, LFB Biomanufacturing.
Articles by Eve DePauw
This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
2
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
3
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
4
FAQ: When Big Pharma Drops a Drug Candidate, Who Picks It Up?
5